Cargando…
Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of both metabolic and inflammatory diseases and has become the leading chronic liver disease worldwide. High-fat (HF) diets promote an increased uptake and storage of free fatty acids (FFAs) and triglycerides (TGs) in hepatocytes,...
Autores principales: | Patton, Ashley, Church, Tyler, Wilson, Caroline, Thuma, Jean, Goetz, Douglas J, Berryman, Darlene E, List, Edward O, Schwartz, Frank, McCall, Kelly D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958349/ https://www.ncbi.nlm.nih.gov/pubmed/29666152 http://dx.doi.org/10.1530/JOE-18-0078 |
Ejemplares similares
-
Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization
por: Courreges, Maria C., et al.
Publicado: (2012) -
SUN-095 Attenuation of Inflammation by a Novel Small Molecule Prevents High Fat Diet-Induced Nonalcoholic Fatty Liver Disease
por: Patton, Ashley, et al.
Publicado: (2019) -
TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration
por: Schwartz, Anthony L., et al.
Publicado: (2016) -
Phenylmethimazole Suppresses dsRNA-Induced Cytotoxicity and Inflammatory Cytokines in Murine Pancreatic Beta Cells and Blocks Viral Acceleration of Type 1 Diabetes in NOD Mice
por: McCall, Kelly D., et al.
Publicado: (2013) -
Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD
por: McCall, Kelly D, et al.
Publicado: (2023)